Letter from China.
作者信息
Guan Wei-Jie, Zhong Nan-Shan
机构信息
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
出版信息
Respirology. 2020 Jun;25(6):657-658. doi: 10.1111/resp.13817. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
Letter from China.来自中国的信。
Respirology. 2020 Jun;25(6):657-658. doi: 10.1111/resp.13817. Epub 2020 Apr 8.
2
Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques.运用动态统计技术对中国新型冠状病毒肺炎（COVID-19）病例进行调查。
Heliyon. 2020 Apr;6(4):e03747. doi: 10.1016/j.heliyon.2020.e03747. Epub 2020 Apr 4.
3
The first confirmed case of COVID-19 in Tanzania: recommendations based on lesson learned from China.坦桑尼亚首例新冠肺炎确诊病例：基于中国经验教训的建议。
Trop Med Health. 2020 Apr 26;48:25. doi: 10.1186/s41182-020-00214-x. eCollection 2020.
4
Strongly Heterogeneous Transmission of COVID-19 in Mainland China: Local and Regional Variation.中国内地新冠病毒肺炎的强异质性传播：局部与区域差异
Front Med (Lausanne). 2020 Jun 19;7:329. doi: 10.3389/fmed.2020.00329. eCollection 2020.
引用本文的文献
1
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19.国家推行儿童普遍卡介苗接种政策与 COVID-19 死亡率降低有关。
Respirology. 2020 Aug;25(8):898-899. doi: 10.1111/resp.13885. Epub 2020 Jun 18.
2
COVID-19: molecular diagnostics overview.COVID-19：分子诊断概述。
J Mol Med (Berl). 2020 Jul;98(7):947-954. doi: 10.1007/s00109-020-01931-w. Epub 2020 Jun 13.
本文引用的文献
1
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
2
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.通过隔离病例和接触者控制 COVID-19 疫情爆发的可行性。
Lancet Glob Health. 2020 Apr;8(4):e488-e496. doi: 10.1016/S2214-109X(20)30074-7. Epub 2020 Feb 28.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana.基于2019年至2020年中国疫情早期指数增长对新型冠状病毒（2019-nCoV）基本繁殖数的估计：对Dhungana的回复
Int J Infect Dis. 2020 May;94:148-150. doi: 10.1016/j.ijid.2020.02.025. Epub 2020 Feb 20.
5
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
6
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
7
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
Zotero 插件